| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/12/2011 | US7977066 Method for preparing tryptophan rich peptides |
| 07/12/2011 | US7977062 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 07/12/2011 | US7977060 Mammalian sweet taste receptors |
| 07/12/2011 | US7977047 Delete sequence in M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 07/12/2011 | US7976849 Hepatitis-C virus testing |
| 07/12/2011 | US7976848 Optimized expression of HPV 58 L1 in yeast |
| 07/12/2011 | US7976846 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor |
| 07/12/2011 | US7976845 Viral protein for use as tool in developing vaccines for prevention and treatment of viral infection |
| 07/12/2011 | US7976844 Fusion proteins of Mycobacterium tuberculosis |
| 07/12/2011 | US7976843 Method for screening peptides for use in immunotherapy |
| 07/12/2011 | US7976840 Use of anti-GL50 antibodies for the downmodulation of an immune response |
| 07/12/2011 | CA2562738C Soluble rubella e1 envelope antigens |
| 07/12/2011 | CA2526957C Long lasting insulin derivatives and methods thereof |
| 07/12/2011 | CA2506318C Unexpected surface proteins in neisseria meningitidis |
| 07/12/2011 | CA2497167C Modified saccharides, conjugates thereof, and their manufacture |
| 07/12/2011 | CA2486738C Method for identifying immunoreactive peptides |
| 07/12/2011 | CA2480162C Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40 |
| 07/12/2011 | CA2468957C Methods of propagation of influenza virus in cell lines over expressing sialyl transferases |
| 07/12/2011 | CA2461443C Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 07/12/2011 | CA2457763C Method and apparatus for separation of milk, colostrum, and whey |
| 07/12/2011 | CA2448947C Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
| 07/12/2011 | CA2440610C Induction of tumor immunity by variants of folate binding protein |
| 07/12/2011 | CA2440195C Synthetic genes and bacterial plasmids devoid of cpg |
| 07/12/2011 | CA2423052C Screening assays for agonists or antagonists of receptor activator of nf-kb |
| 07/12/2011 | CA2415348C Isolated polynucleotide sequences encoding a fertility associated antigen |
| 07/12/2011 | CA2408851C Methods for refolding proteins containing free cysteine residues |
| 07/12/2011 | CA2405438C Hepatitis b core antigen fusion proteins |
| 07/12/2011 | CA2397347C Factor vii or viia-like molecules |
| 07/12/2011 | CA2396744C Synthetic lipid-a analogs and uses thereof |
| 07/12/2011 | CA2393200C Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 07/12/2011 | CA2392046C Biglycan and uses thereof in stabilizing dystrophin associated protein complexes |
| 07/12/2011 | CA2362527C A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
| 07/12/2011 | CA2355399C Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases |
| 07/12/2011 | CA2352286C Intracellular targeted delivery of compounds by 70 kd heat shock protein |
| 07/12/2011 | CA2329133C Recombinant venezuelan equine encephalitis virus vaccine |
| 07/12/2011 | CA2325058C Mammalian tolloid-like gene and protein |
| 07/12/2011 | CA2312274C Isolated dna encoding human h3 histamine receptor |
| 07/12/2011 | CA2302874C Jnk3 modulators and methods of use |
| 07/12/2011 | CA2291514C Methods for evaluating tissue morphogenesis and activity |
| 07/12/2011 | CA2220442C Chromatin regulator genes |
| 07/12/2011 | CA2182976C Active immunization using a siderophore receptor protein |
| 07/12/2011 | CA2162555C Method for the culture in vitro of different stages of tissue parasites |
| 07/12/2011 | CA2162262C Methods for treating muscle diseases and disorders |
| 07/07/2011 | WO2011082422A2 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications |
| 07/07/2011 | WO2011082381A2 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 07/07/2011 | WO2011082345A2 Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof |
| 07/07/2011 | WO2011081904A1 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 07/07/2011 | WO2011081598A1 New antigens for use in a vaccine against h.pylori infection |
| 07/07/2011 | WO2011081523A1 Interferon analogs |
| 07/07/2011 | WO2011081366A2 Beef-specific age determination marker containing the p21 protein |
| 07/07/2011 | WO2011081075A1 Method for extracting staphylococcus aureus antigen, reagent for extracting staphylococcus aureus antigen, and method for testing staphylococcus aureus |
| 07/07/2011 | WO2011080342A1 Administration route for a composition to protect an animal against rhodococcus equi |
| 07/07/2011 | WO2011080329A2 Gpav gene resistant to nematodes in the nightshade family |
| 07/07/2011 | WO2011080267A2 Polypetides having detergency enhancing effect |
| 07/07/2011 | WO2011080103A1 Double-acylated glp-1 derivatives |
| 07/07/2011 | WO2011080102A2 Glp-1 analogues and derivatives |
| 07/07/2011 | WO2011079817A1 Dendrimer of tuftsin and influenza matrix protein，and use thereof |
| 07/07/2011 | WO2011066511A8 Synthetic apoa-1 mimetic amphipathic peptides and methods of use thereof |
| 07/07/2011 | WO2011062354A3 Method for preparing gintonin, which is a novel glycolipoprotein from panax ginseng, and gintonin, which is a novel glycolipoprotein, prepared by the method |
| 07/07/2011 | WO2011053790A3 Assay of closely linked genetic targets in fetal diagnosis |
| 07/07/2011 | WO2011050985A8 Clonal expansion of b cells |
| 07/07/2011 | WO2011048614A3 Short chain peptidomimetics based orally active glp-1 agonist and glucagon receptor antagonist |
| 07/07/2011 | WO2010147803A3 Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes |
| 07/07/2011 | WO2010083518A3 Thermohemicellulases for lignocellulosic degradation |
| 07/07/2011 | WO2010061283A8 Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis |
| 07/07/2011 | US20110167522 Cyclin d polynucleotides, polypeptides and uses thereof |
| 07/07/2011 | US20110167520 Xenorhabdus sp. genome sequences and uses thereof |
| 07/07/2011 | US20110167517 Identification of diurnal rhythms in photosynthetic and non-photsynthetic tissues from zea mays and use in improving crop plants |
| 07/07/2011 | US20110167507 Animal Model Having a Chimeric Human Liver and Suceptible to Human Hepatitis C Virus Infection |
| 07/07/2011 | US20110166336 Identification of New Small RNAs and ORFs of E. Coli as Mediators of Cell and Intercell Regulation |
| 07/07/2011 | US20110166325 Collagen fibrillar construction |
| 07/07/2011 | US20110166324 Immunosuppressive polypeptides and nucleic acids |
| 07/07/2011 | US20110166323 Chimeric, hybrid and tandem polypeptides of meningococcal nmb1870 |
| 07/07/2011 | US20110166322 Alpha-conotoxin peptides |
| 07/07/2011 | US20110166321 Double-acylated glp-1 derivatives |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166208 Nucleotide and Amino Acid Sequences for Calmodulin Protein Methyltransferase |
| 07/07/2011 | US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 07/07/2011 | US20110166145 Stabilization of hypoxia inducible factor (HIF) alpha |
| 07/07/2011 | US20110166076 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases |
| 07/07/2011 | US20110166072 Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof |
| 07/07/2011 | US20110166071 Method for synthesizing thymosins |
| 07/07/2011 | US20110166067 Methods for inhibition of scarring |
| 07/07/2011 | US20110166066 Catestatin (cst) and its variants for treatment of cardiovascular and metabolic disorders |
| 07/07/2011 | US20110166064 Halogen-stabilized insulin |
| 07/07/2011 | US20110166063 Polymer conjugates of therapeutic peptides |
| 07/07/2011 | US20110166062 Gip-based mixed agonists for treatment of metabolic disorders and obesity |
| 07/07/2011 | US20110166061 Long lasting fusion peptide inhibitors for hiv infection |
| 07/07/2011 | US20110166059 Means and methods for evaluating a therapy with a p38 map kinase inhibitor |
| 07/07/2011 | US20110165936 Gaming system network and method for delivering gaming media |
| 07/07/2011 | US20110165680 Clean genome bactofection |
| 07/07/2011 | US20110165678 New Tomato Ethylene Response Factors and Uses Thereof |
| 07/07/2011 | US20110165668 MHC Class I Peptide Epitopes from the Human 5T4 Tumor-Associated Antigen |
| 07/07/2011 | US20110165656 Fungal transcriptional activators useful in methods for producing a polypeptide |
| 07/07/2011 | US20110165649 Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts |
| 07/07/2011 | US20110165647 Nanoparticle conjugates |
| 07/07/2011 | US20110165633 Production of Polyketides and Other Natural Products |
| 07/07/2011 | US20110165627 Gene site saturation mutagenesis |
| 07/07/2011 | US20110165624 Protein purification tags and uses thereof |
| 07/07/2011 | US20110165623 Compositions and Methods for the High Efficiency Expression of the Transforming Growth Factor-Beta Supergene Family |